Connection

David Cachia to Humans

This is a "connection" page, showing publications David Cachia has written about Humans.
Connection Strength

0.519
  1. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. J Neurol Sci. 2020 Nov 15; 418:117102.
    View in: PubMed
    Score: 0.028
  2. MGMT-inhibitor in combination with TGF-?RI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells. Clin Transl Oncol. 2021 Mar; 23(3):612-619.
    View in: PubMed
    Score: 0.028
  3. In?Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells. Cancer Invest. 2020 Jul; 38(6):349-355.
    View in: PubMed
    Score: 0.028
  4. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations. Clin Transl Oncol. 2020 Nov; 22(11):2017-2025.
    View in: PubMed
    Score: 0.027
  5. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol. 2020 Jul; 22(7):1138-1145.
    View in: PubMed
    Score: 0.027
  6. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.
    View in: PubMed
    Score: 0.025
  7. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
    View in: PubMed
    Score: 0.023
  8. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.020
  9. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol. 2015 Apr; 122(2):391-8.
    View in: PubMed
    Score: 0.019
  10. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11.
    View in: PubMed
    Score: 0.019
  11. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11.
    View in: PubMed
    Score: 0.019
  12. A case of early-onset rapidly progressive dementia. JAMA Neurol. 2014 Nov; 71(11):1445-9.
    View in: PubMed
    Score: 0.019
  13. Middle cerebral artery territory infarct due to Cryptococcus infectionstitle: an uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopathol. 2015 Aug; 43(8):632-4.
    View in: PubMed
    Score: 0.019
  14. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
    View in: PubMed
    Score: 0.018
  15. Child Neurology: cognitive delay in a 7-year-old girl. Neurology. 2013 Nov 12; 81(20):e148-50.
    View in: PubMed
    Score: 0.018
  16. A rare presentation of hypertrophic olivary degeneration secondary to primary central nervous system lymphoma. JAMA Neurol. 2013 Sep 01; 70(9):1192-3.
    View in: PubMed
    Score: 0.017
  17. Brachial amyotrophic diplegia in the setting of complete HIV viral load suppression. BMJ Case Rep. 2012 Dec 06; 2012.
    View in: PubMed
    Score: 0.016
  18. Widely metastatic meningioma. Arch Neurol. 2012 Oct; 69(10):1372-3.
    View in: PubMed
    Score: 0.016
  19. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2022 09 12; 9:CD011376.
    View in: PubMed
    Score: 0.008
  20. Establishing a Standardized Method for the Effective Intraoperative Collection and Biological Preservation of Brain Tumor Tissue Samples Using a Novel Tissue Preservation System: A Pilot Study. World Neurosurg. 2022 05; 161:e61-e74.
    View in: PubMed
    Score: 0.008
  21. Current Use and Limitations of Cultured High-Grade Meningioma Cells in Neuro-Oncological Research - In Response to: "Caution Using Meningioma Cell Lines as Tumor Models". Cancer Invest. 2022 02; 40(2):132-133.
    View in: PubMed
    Score: 0.008
  22. Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG. J Clin Neurophysiol. 2021 Mar 01; 38(2):143-148.
    View in: PubMed
    Score: 0.007
  23. Analysis of the P53N a Novel Protein Encoded on Chromosome 22q12.1-12.3 in Glioblastomas and Ependymomas Specimens. J Mol Neurosci. 2021 Aug; 71(8):1714-1722.
    View in: PubMed
    Score: 0.007
  24. Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial. JAMA Oncol. 2020 12 01; 6(12):1939-1946.
    View in: PubMed
    Score: 0.007
  25. Analysis of P78: A Novel Cytoplasmic Membrane-Associated Protein Encoded on Chromosome 19q13.3 in Glioma Specimens. J Mol Neurosci. 2020 Sep; 70(9):1415-1424.
    View in: PubMed
    Score: 0.007
  26. Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases. J Neurol Sci. 2019 Dec 15; 407:116538.
    View in: PubMed
    Score: 0.007
  27. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer. 2019 05; 112:83-93.
    View in: PubMed
    Score: 0.006
  28. Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features. J Neurol Sci. 2019 May 15; 400:34-38.
    View in: PubMed
    Score: 0.006
  29. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nat Med. 2019 01; 25(1):176-187.
    View in: PubMed
    Score: 0.006
  30. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro Oncol. 2018 01 10; 20(1):113-122.
    View in: PubMed
    Score: 0.006
  31. Ependymomas arising outside of the central nervous system: A case series and literature review. J Clin Neurosci. 2018 Jan; 47:202-207.
    View in: PubMed
    Score: 0.006
  32. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol. 2017 Feb; 92(2):155-160.
    View in: PubMed
    Score: 0.005
  33. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21.
    View in: PubMed
    Score: 0.005
  34. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
    View in: PubMed
    Score: 0.005
  35. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2016 Apr 13; 4:CD011376.
    View in: PubMed
    Score: 0.005
  36. Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. Neurosurgery. 2016 Mar; 78(3):E466-73.
    View in: PubMed
    Score: 0.005
  37. Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenstr?m's macroglobulinemia. Ann Hematol. 2016 Jan; 95(2):347-8.
    View in: PubMed
    Score: 0.005
  38. Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center. J Neurooncol. 2015 Oct; 125(1):143-8.
    View in: PubMed
    Score: 0.005
  39. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
    View in: PubMed
    Score: 0.005
  40. Peripheral neuropathy after hair dye exposure: a case report. J Clin Neuromuscul Dis. 2014 Jun; 15(4):161-3.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.